Similar Articles
1271 Hepatitis B virus reactivation in patients with hepatocellular carcinoma undergoing anti-cancer therapy
1272 DNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma
1273 Roles of Tregs in development of hepatocellular carcinoma: A meta-analysis
1274 Evaluation of endoscopic biliary stenting for obstructive jaundice caused by hepatocellular carcinoma
1275 Inflammatory markers as selection criteria of hepatocellular carcinoma in living-donor liver transplantation
1276 Liver resection in hepatitis B related-hepatocellular carcinoma: Clinical outcomes and safety in elderly patients
1277 Prognostic factors for hepatocellular carcinoma recurrence
1278 Occult hepatitis B virus and hepatocellular carcinoma
1279 miR-106b-25/miR-17-92 clusters: Polycistrons with oncogenic roles in hepatocellular carcinoma
1280 MicroRNAs as therapeutic strategy for hepatitis B virus-associated hepatocellular carcinoma: Current status and future prospects
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA